-
Current Trial (Cohorts A–C): Sernova’s current cohorts are focused on testing the safety and tolerability of transplanting donor islets (from cadaveric pancreases) into Sernova’s Cell Pouch device in T1D patients.
-
Future Direction (Post-Cohort C): Next, Sernova plans to launch a new clinical trial using iPSC-derived islet-like clusters, instead of relying on donor islets. This will be in collaboration with Evotec, a leading iPSC company.
-
Why iPSCs Matter: iPSC-derived islet-like clusters offer a renewable, potentially unlimited cell source for treating T1D, overcoming the limitations of donor availability. This aligns with Sernova’s goal of developing a scalable and widely accessible solution.
How Human iPSCs are Revolutionizing Drug Discovery in 2025
Drug discovery involves high cost and uncertain outcomes. Only a few companies can take the risk of investing enormous amounts of money into research and testing, only to see undesirable side effects emerge during the final human clinical trials. In many cases, companies are spending millions of dollars to fail during clinical testing.
Thankfully, some new medicines are now being tested for safety on specialized cells developed from human pluripotent cell lines. Cell types which are increasingly being used within drug discovery applications include heart (cardiomyocytes) and liver cells (hepatocytes), which are the organs where 80% of drug failures occur. [Read more…]
The Growing Market for Research Peptides: Opportunities and Risks
The research peptide market has grown substantially in recent years. What was once largely confined to academic laboratories has expanded into a broader research ecosystem that includes contract research organizations (CROs), biotechnology companies, and independent researchers exploring the scientific potential of peptides.
It is not simply a passing trend. Growing interest in peptides reflects expanding scientific research into their biological functions and potential research applications.
The Growing Profile of Peptide Research
Peptides are short chains of amino acids that are generally smaller than proteins. Their relatively defined structures, combined with advances in synthesis and modification techniques, have made them valuable tools for studying a wide range of biological processes, including metabolism, cellular signaling, and tissue repair.
Many researchers study peptides because of their roles in cellular signaling and other biological pathways. Some peptides are designed to interact with relatively specific biological targets, although their properties and potential applications vary considerably depending on the individual compound and the context of the research.
That scientific potential comes with practical challenges. Quality standards and manufacturing practices can vary considerably among suppliers, particularly within the research-use-only (RUO) marketplace. As a result, product purity, storage conditions, documentation, and labeling may differ more than many purchasers expect.
Two products marketed under the same peptide name may differ in purity, composition, stability, or handling, potentially affecting research outcomes and reproducibility. For researchers seeking reliable, repeatable data, supplier quality and analytical documentation can therefore be just as important as the peptide itself.
This helps explain why discussions surrounding certain compounds often focus not only on their biological characteristics, but also on how they are manufactured, tested, and sourced. References to compounds such as klow peptide are often accompanied by discussions of analytical verification, product documentation, and supplier quality practices, in addition to the peptide itself.
Accessibility Doesn’t Mean Simplicity
A common misconception is that because peptides can be relatively straightforward to synthesize or obtain for research purposes, they require less rigorous laboratory practices. In reality, high-quality peptide research still depends on appropriate laboratory procedures, controlled handling, accurate documentation, and well-designed experimental protocols.
Without appropriate controls and quality assurance measures, research results may be difficult to reproduce or interpret.
Although the barrier to entry may be lower than in some other areas of biomedical research, meaningful peptide research still requires careful planning, technical expertise, and disciplined experimental design.
The Supply Side
The research peptide marketplace includes suppliers serving different segments of the research community, with varying approaches to quality assurance, analytical testing, documentation, and manufacturing practices.
Financial cost is only one consideration when selecting a supplier. Products with inconsistent quality or insufficient characterization can compromise experimental results, making it difficult to draw reliable conclusions or reproduce findings.
Researchers who prioritize quality often look beyond marketing claims and instead evaluate factors such as:
- Purity data, ideally supported by independent analytical testing
- Consistent batch documentation
- Transparent storage, handling, and shipping procedures
- Evidence-supported descriptions of a peptide’s characteristics and intended research use
Researchers should carefully evaluate marketing claims that are not supported by appropriate scientific documentation or analytical testing.
Future Directions
Many industry observers expect interest in research peptides to continue growing as scientific understanding advances and peptide synthesis technologies become more efficient.
As the market evolves, suppliers may become increasingly differentiated. Some organizations are expected to invest in more comprehensive quality systems and documentation practices that resemble those used within regulated pharmaceutical manufacturing, while others may continue to serve the broader research marketplace with varying levels of quality assurance.
Regardless of how the industry develops, long-term success for researchers will continue to depend on disciplined risk management, careful supplier evaluation, rigorous experimental design, and a strong commitment to quality, compliance, and due diligence.
It is also important to recognize that many research peptides are marketed exclusively for laboratory research purposes and are not approved as drugs, dietary supplements, or medical treatments. Regulatory requirements vary by jurisdiction, and purchasers should ensure that any acquisition, handling, storage, and use complies with applicable laws, regulations, institutional policies, and ethical standards.
Disclaimer: This article is provided solely for general informational and educational purposes. It does not constitute medical, scientific, legal, or regulatory advice, nor does it endorse or recommend any specific product, supplier, or research peptide. References to research peptides are intended solely to discuss laboratory research and industry practices. Readers are responsible for independently evaluating suppliers, verifying product quality, and ensuring compliance with all applicable laws, regulations, institutional policies, and ethical standards. Products designated as “Research Use Only (RUO)” should be used exclusively in accordance with their intended purpose and applicable legal requirements.
PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: KGF alternative peptide (FGFR2b agonist)
PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called “KGF alternative- peptide (FGFR2b agonist)” which is functionally equivalent to recombinant keratinocyte growth factor (KGF). This product will be on the market beginning April 2025. [Read more…]
The Role of iPSCs in Farm Animals and Wildlife Conservation
Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have been potently transforming regenerative medicine, biotechnology, and conservation. Their ability to be reprogrammed from adult somatic cells unlocks new possibilities for enhancing farm animal reproduction, boosting disease resistance, and improving food quality, while also playing a pivotal role in wildlife conservation and species revival. However, their use raises ethical concerns, including the risks of genetic modification, unforeseen ecological consequences, and the moral dilemmas surrounding species de-extinction. [Read more…]
- « Previous Page
- 1
- …
- 62
- 63
- 64
- 65
- 66
- …
- 338
- Next Page »




